Celestra (352770) | AccidentalOrder

KOSDAQ · 5,250 KRW · As of Aug 26, 2026 close

Mkt Cap

13.6B

Rev (2025)

2.0B

Op Inc (2025)

-7.8B

Net Inc (2025)

-11.8B

52W

5K~5K

Celestra operates in the Pharmaceuticals sector.

Legal name: Celestra Inc.

In fiscal year 2025, Celestra (352770) reported revenue of 2.0 billion KRW, down 76.4% from 8.5 billion KRW a year earlier.

Operating profit was -7.8 billion KRW and net income was -11.8 billion KRW in the same year.

As of the Aug 26, 2026 close, the market capitalization was 13.6 billion KRW.

These figures can be verified in the DART filing (receipt no. 20260407002850).

Year	Rev	Op Inc	Net Inc
2025	2.0B	-7.8B	-11.8B
2024	8.5B	-28.7B	-47.1B
2023	11.4B	-34.6B	-42.4B

5 applicable out of 8 items

기타시장안내 (회생절차 폐지결정 관련 시장조치 미진행)

회생절차폐지결정

기타시장안내 (상장적격성 실질심사 사유 추가 관련 절차 미진행)

Checks

5 of 8 checked items currently applicable.

Market Cap & Price: Market cap is below the delisting threshold for 342 consecutive days.

Administrative Designation: 5 administrative designation criteria met. [source]

Audit Opinion: Audit opinion: Disclaimer of opinion. [source]

Convertible Bonds: Convertible bonds outstanding with 0.9% potential dilution.

Capital Increase: No capital-increase filings in the last 180 days.

Treasury Stock: No treasury stock filings.

Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.

Major Shareholder Change: No major shareholder changes in the last 180 days.

Market Action: 13 market action(s) (trading halt, delisting, etc.) recorded. [source]

These checks are mechanical tests of disclosed figures and do not constitute investment advice or recommendations.

Date	Filing
2026-08-24	기타시장안내 (회생절차 폐지결정 관련 시장조치 미진행)
2026-08-24	회생절차폐지결정
2026-08-14	기타시장안내 (상장적격성 실질심사 사유 추가 관련 절차 미진행)
2026-08-14	Semi-Annual Review Adverse Opinion (Capital Erosion 50%+ or Equity Below 1B)
2026-08-14	반기또는분기매출액미달사실발생